Medicine
HealthScientists map a road to fairer, more inclusive drug development
Only 6% of pivotal U.S. drug trials reflect national diversity, putting true precision medicine out of reach for many patients.
Melanie Livingstone
Only 6% of pivotal U.S. drug trials reflect national diversity, putting true precision medicine out of reach for many patients.
Melanie Livingstone